“Muricins as Potential Natural B-cell Lymphoma-extra-large (Bcl-xL) Inhibitors: A Multiscale in Silico Approach Targeting Apoptosis and Chemoresistance in Cancer”, Mal. J. Fund. Appl. Sci., vol. 22, no. 3, pp. 517–537, Jul. 2026, doi: 10.11113/mjfas.v22n3.4885.